Skip to main content

Thrive Earlier Detection Acquired in $2.15B Deal by Molecular Diagnostics Company Exact Sciences

Baltimore City - based, Thrive Earlier Detection Corp., a JHU cancer diagnostic spinoff, has been acquired by molecular diagnostics company Exact Sciences in a $2.1B deal to further advance development of CancerSEEK, a liquid biopsy test designed to detect multiple types of cancer at early stages. “We believe that this combined team can transform the future of cancer diagnostics,” said Kevin Conroy, CEO of Exact Sciences.


Read More

 
Michele Whelley - President & CEO

"We want you to be informed about Greater Baltimore. Don't be shy; please ask."

Michele Whelley
President & CEO

We are here to help you!

If you've landed on this site, then you have questions about us, and we want to help. We know that your time is crucial, and getting access to us should not be a complicated thing. Drop us a note via one of the options below and we will get back to you within 24 hours.

(410) 864-9927